Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat ITP ...Middle East

The oral BTK inhibitor rilzabrutinib led to rapid and durable platelet responses, reduced bleeding, and improved fatigue in patients with previously treated immune thrombocytopenia. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat ITP )

Also on site :

• At Least 11 Dead After Driver Plowed Into Crowd at a Filipino Festival in Vancouver
• What to know about the trial of an ex-Michigan cop charged in the killing of a Black motorist
• U.S. Military Says Its Air Campaign Has Hit More Than 800 Targets in Yemen